Abstract: Primary care practices become patient-centered medical homes (PCMHs) to improve care. However, investment costs and opportunities to offset those costs are critical to the decision. We examined potential offsets through commercial payer per-member-per-month (PMPM) payments and the Medicare Merit-based Incentive Payment System (MIPS) for a network that spent $4 818 260 over 4 years obtaining and renewing PCMH recognition for 57 practices. With PMPM payments of $3.37 to $8.98, "breakeven" requires that 2.4% to 6.4% of the network's 1645 commercially insured patients per physician be covered, while applying MIPS incentive payments of half the maximum available each year to the network's average 2016 Medicare reimbursement of $196 812 per physician showed they would exceed PCMH costs by 2022.
and health care resource utilization (Edwards et al., 2014; Friedberg et al., 2014; Hebert et al., 2014; Homer & Baron, 2010; Jackson & Williams, 2015; Neal et al., 2015; Nelson et al., 2014; Patel et al., 2013; Yoon et al., 2016) ultimately lands in its favor, this information will be of limited use if we have not simultaneously developed a reimbursement strategy that enables and incentivizes practices to adopt this model while sustaining their financial performance.
Currently, there is little real-world evidence available to guide practices' decisions about investing in PCMH transformation. Outside of a study conducted in the unique setting of the Veterans Health Administration , reports of the costs of transformation have largely been limited to the experience of small numbers of independent practices (Halladay et al., 2016; Ho & Antonucci, 2015) or have focused on very specific aspects of supporting PCMH-related activities (such as staffing costs) (Magill et al., 2015; Patel et al., 2013) . Studies looking at reimbursement models for PCMH activities have either excluded the up-front costs of transformation (Basu et al., 2016) or excluded the costs of necessary supporting resources (such as care coordination and information infrastructure) supplied by a centralized entity across a broader network of practices (Cuellar et al., 2016) . We recently reported both the practice-level and centralized corporate costs for a large physician network implementing and sustaining the PCMH model across its 57 primary care practices (Fleming et al., 2017) . Here, we compare these costs with the "per member per month" (PMPM) case management/care coordination fees reported to be available from various payers to practices that maintain PCMH recognition and to the incentive payments PCMH recognition will potentially assist physicians/practices under the Merit-based Incentive Payment System (MIPS) track as the reimbursement structures authorized under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) are implemented.
METHODS

Setting
HealthTexas Provider Network (HTPN) is the fee-for-service ambulatory care provider network affiliated with Baylor Scott & White Health, a not-for-profit health care system, in North Texas. As reported elsewhere, a common electronic health record (EHR) was implemented across all HTPN primary care practices between 2006 and 2008 (Fleming et al., 2011) , and between June 2010 and 2012, all 57 HTPN primary care practices obtained recognition from the National Committee for Quality Assurance (NCQA) as level III PCMHs under the 2008 criteria, renewing 3 years later under either the 2011 or 2014 criteria (Fleming et al., 2017) .
Data collection and analysis
We previously combined data regarding the time and effort expended by individuals in both the HTPN corporate resources supporting PCMH transformation and maintenance activities and the individual practices, with payroll and expense data, to determine the overall and corporate-and practice-level incremental costs associated with the initial transformation of HTPN primary care practices to PCMHs, ongoing activities, and required renewals (Fleming et al., 2017) . These costs were assessed at the global HTPN corporate and practice levels, as the time and resources devoted to these activities impact all HTPN primary care patients, not only those for whom PCMH-related PMPM payments are available or who will contribute to MIPS scores.
From HTPN administrative data, we determined the average size and payer distribution of an HTPN primary care physician's patient panel, as well as average annual Medicare reimbursement per physician.
From the literature, we identified the range (and median) of the PMPM payments assorted initiatives and payers have offered to support PCMH-related activities to determine what percentage of the average physician patient panel would need to be covered by such a payment for HTPN to offset the investment costs of PCMH transformation and maintenance in 4 years-a time period selected to capture the initial transformation costs, the first renewal (after 3 years), and the ongoing activity costs (eg, care coordination).
Because PCMH recognition can assist primary care physicians earn performance awards under the MIPS track within MACRA, we also compared cumulative total and practice-level costs with the awards a single hypothetical average 5-physician HTPN practice could earn and that the network of 57 PCMHs could earn. To provide a picture useful to physician networks currently debating whether to initiate PCMH transformation, we "moved" HTPN's initial transformation to 2016. For these comparisons, we applied both a "best case scenario" in which all 57 practices would earn the maximum award under MIPS (4% of Medicare Part B payments in 2019, 5% in 2020, 7% in 2021, and 9% from 2022 onwards) (Centers for Medicare & Medicaid Services, 2017b) and a more realistic scenario under which the awards would average out at half the available maximum reward (eg, 2% in 2019; 4.5% from 2022 onward). For simplicity, we converted all HTPN dollar amounts to 2016 US dollars using the Consumer Price Index (CPI) annual percent changes for medical care reported for Dallas-Fort Worth by the US Bureau of Labor Statistics; the range of PMPM payments obtained from the literature was converted using the US City Average CPI annual percentage changes for medical care, as they were based on a national survey (Bureau of Labor Statistics, 2017). We have previously estimated HTPN's incremental costs associated with its 57 primary care practices obtaining and maintaining level III NCQA PCMH recognition in 2012 US dollars (Fleming et al., 2017 A national survey of PCMH initiatives conducted in 2013 reported a median (interquartile range) of the PMPM payments available at $4.90 ($3.00-$8.00) (Edwards et al., 2014) . In 2016 US dollars, these were equivalent to PMPM payments of $5.50 ($3.37-$8.98). Table 2 shows the percentage of patients that would need to be covered by a PMPM payment for HTPN to "breakeven" by year 4 under a low ($3.37), median ($5.50), and high ($8.98) payment scenario. Table 3 compares the PCMH costs versus potential MIPS payments for 2017 to 2022 had PCMH transformation taken place in 2016. Under either scenario examined (earning the maximum MIPS incentive available or earning on average half the maximum MIPS incentive available), a hypothetical 5-physician practice's MIPS incentive payments would exceed its spending on obtaining and maintaining NCQA PCMH recognition from the firstyear of MIPS payments onward. In terms of total HTPN spending (corporate plus practice costs), under the scenario in which all physicians at all practices earn the maximum MIPS incentive every year it is available, the cumulative incentive payments received would exceed the cumulative spending on obtaining and maintaining NCQA recognition from 2021 onward. Under the scenario in which physicians earned, on average, half the maximum MIPS incentive available, this would take until 2022.
RESULTS
In
DISCUSSION
Our results show that, while transforming primary care practices into recognized PCMHs involves significant up-front investment, in the context of a large physician network such as HTPN that is able to provide centralized support both for the transformation process and for ongoing PCMH-related activities such as care coordination, offsetting these costs can realistically be achieved through such PMPM payments as payers have reportedly offered to date. Even at the low end of the reported PMPM range for practices achieving level III NCQA recognition ($3.37 PMPM), our results show that only 6.4% of HTPN's commercially insured primary care patients would need to be covered by plans offering such payments for HTPN to offset its full expenditure (including initial PCMH recognition, one renewal, and ongoing PCMH-related activities such as care coordination) within 4 years. We also estimate that, for a network such as HTPN that chose to initiate PCMH transformation of its primary care practices in 2016 to help those practices qualify for higher performance scores and awards under the MIPS track in MACRA, it would be possible to offset the cumulative expenditures by 2022 if the physicians in that network earned, on average, half of the maximum MIPS performance award available from 2019 onward. Having based our evaluation on a hypothetical "average" practice, our results do assume a degree of cross-subsidization, in which some physicians and practices earn greater MIPS incentive payments or have larger numbers of patients with PMPM payments related to PCMH recognition than others. Cross-subsidization could be direct, for example, requiring practices with higher MIPS or PMPM earnings to contribute more of those specific earnings toward the centralized support for the PCMH initiative. Alternatively, it could be unrelated to PMPM or MIPS incentive payments, with practices contributing funds toward central resources (supporting various network-level initiatives, including the PCMH initiative) based on non-performance-based factors such as the number of physicians in the practice. Our results regarding the ability to offset PCMH transformation and maintenance costs through PMPM payments with less than 10% of commercial patients covered stand in contrast to the experience reported an early PCMH adopter, who found the $3 to $7 PMPM payments insufficient to maintain care coordinators on his payroll and cover the costs for the required data reportingparticularly since the attribution of patients for which he received these PCMH payments "always seemed to be less than half of the actual patients [he] was seeing with other payers" (Bender, 2015) . An important part of this difference may well be the centralized support HTPN was able to offer-both for the process of applying for and renewing PCMH recognition and for ongoing services such as care coordination and automated reporting of the necessary quality measures. As we have previously reported, this centralized support reduced the time spent by physicians and practice staff on obtaining PCMH recognition from the 500 hours reported by solo practices (Ho & Antonucci, 2015) to an estimated 240 hours (Fleming et al., 2017) . Our results are also worth considering in light of the recent microsimulation model that found practices could add substantial additional net revenue through PMPM payments (with or without pay-for-performance awards) related to PCMH recognition, provided the practices implement only the minimum requirements to qualify for the payments (Basu et al., 2016) . Our estimates are consistent with the simulation results to the extent that they suggest that revenue gains could be fairly readily achieved (assuming that at least 10% of commercially insured patients were covered by a plan offering a PMPM payment)-but may show that, in the context of a large network that provides centralized support for PCMH transformation and activities, these gains need not be lost by exceeding the minimum requirements to qualify for the PMPM payments. While we did not specifically examine the extent to which the HTPN practices have implemented the PCMH model, HTPN policy required them to achieve the highest level (III) of NCQA recognition-whereas the microsimulation took into account that payers responding to a national survey regarding PCMH initiatives frequently accepted more basic PCMH standards (eg, NCQA level I) (Basu et al., 2016; Edwards et al., 2014) . Furthermore, the microsimulation did not include up-front costs of PCMH transformation (due to these being highly variable between settings) (Basu et al., 2016) , whereas these represent a large portion of the costs that would need to be offset in our results. As such, our results provide hope that the current PMPM-based PCMH payment structure need not disincentivize implementation of more than the minimum required PCMH standards. 4% in 2019, 5% in 2020, 7% in 2021, and 9% in 2022) ; the "1/2 Max." scenario assumes the average MIPS incentive earned across the network was half of the maximum (ie, 2% in 2019, 2.5% in 2020, etc) . Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Our estimates of how PCMH implementation and maintenance costs compare with the rewards that PCMH recognition can help primary care physicians/practices earn through MIPS incentive payments also provide useful information for physician networks currently considering initiating PCMH transformationor maintaining the PCMH recognitions they have already obtained.
MIPS enables practices participating in Medicare to earn payment adjustments based on evidence-based and practice-specific quality data (Centers for Medicare & Medicaid Services, 2017a). The MIPS Composite Performance Score will factor in 4 weighted categories: quality, improvement activities, advancing care information, and costalthough the weight of this last category will be 0% for the transition year of 2017 (Centers for Medicare & Medicaid Services, 2016 Our results need to be considered in the context we investigated: a large physician network that committed to providing centralized support for PCMH transformation, including some ongoing activities such as care coordination and tracking and reporting quality of care measures. As we have previously reported, this substantially reduced the time and cost burden on the individual practices (Fleming et al., 2017) . Furthermore, we examined incremental costs associated with the practices obtaining and maintaining NCQA level III recognition-since the practices already routinely engaged in many of the activities required to meet the NCQA criteria, the incremental costs do not represent the full cost of PCMH-related activities. Solo practices, or smaller groups of practices, that do not have access to centralized resources similar to those HTPN offers and practices in which the routine daily activities do not already incorporate many of the NCQA PCMH criteria might therefore have very different costs, which may not be offset by the available PMPM payments or MIPS incentive payments to the same extent. Similar cautions apply to practices that have not already implemented an EHR capable of supporting the data-drive aspects of the PCMH model-although the rising adoption of EHRs in primary care should lessen this concern (Xierali et al., 2013) -and practices in which a more clinically and/or socially complex patient mix requires greater care coordination support (thus potentially increasing that category of cost, although, as we previously noted, care coordination activities that focus on bringing patients into the office for overdue preventive or disease management services reimbursable under fee-for-service mechanisms can help offset the care coordination personnel costs) (Fleming et al., 2017) . Finally, because the HTPN practices obtained their initial PCMH recognition in 2010-2012, they did so under the 2008 NCQA criteria, which differed from the current criteria, and it is not known to what extent those differences impact the time and resources required for initial transformation and recognition. In addition, the time estimates from which we calculated costs were based on information obtained through interviews and surveys and so may be subject to recall-and-response bias.
As primary care practices increasingly operate in network contexts similar to HTPN (Bishop et al., 2016; Kirchhoff, 2013) , our results should prove useful to many of those still considering engaging in PCMH transformation or trying to accommodate the up-front investment in their budgets. We show that when the network provides centralized support for the PMCH initiative, costs can be offset within 4 to 6 years at both the practice and network levels with relatively small numbers of commercially insured patients covered by PMPM payments or Medicare MIPS incentive payments averaging at half the maximum available. For practices with patient panels that provide access to both types of payments, investment costs can be offset even more rapidly.
